Urinary Bladder Cancer antigen
UBC
TM is a highly efficient, non-invasive tool in the management of patients with bladder cancer, where UBC concentrations have been reported to be associated with both stage and grade of the tumours. Further, UBC shows high sensitivity also for low stage disease.

UBC
TM is a quantitative urine monoclonal assay with reactivity against defined epitope structures on cytokeratins 8 and 18.


UBCTMII ELISA is a solid phase sandwich assay based on immunochemical technique. Standards, controls and samples react simultaneously with solid phase catcher antibodies (6D7 and 3F3) and the HRP conjugated detector antibody during incubation in the microstrip wells. After washing, the TMB substrate is added. Subsequently the reaction is stopped and the absorbance is read. The developed colour is directly proportional to the concentration of the analyte.